spacer
home > ict > winter 2020 > we can do better: key considerations for paediatric trial success
PUBLICATIONS
International Clinical Trials

We Can Do Better: Key Considerations for Paediatric Trial Success




Parents naturally become anxious when their children are unwell, and that is generally increased when the child needs hospital treatment or when certain procedures, surgery, or conditions are mentioned. In such settings, parents may not be immediately receptive to enquiries about their child participating in clinical research. However, once the discussion with the investigator is underway, a range of additional obstacles often come to the surface, many of which we have the ability to minimise.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Mark Sorrentino, MD and MS, Vice President of the Center for Pediatric Clinical Development, at PRA Health Sciences has more than 20 years of experience in the pharma and biotechnology industries and currently leads PRA’s global paediatric centre of excellence. Mark holds an appointment as an Assistant Clinical Professor at the George Washington University School of Medicine, US. Prior to joining PRA, he spent five years as the Global Chair and Founder of the paediatric practice area at a leading CRO, overseeing all aspects of strategy and paediatric clinical development, and the Global Therapeutic Head of Critical Care.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Cargo Convoy Departs to China Carrying Medical Supplies Donated by Qatar Airways for Coronavirus Relief

2,500,000 face masks and 500,000 bottles of hand sanitizer have been donated by Qatar Airways
More info >>

White Papers

Is Your Biobank Ready for the Challenge of Biomarker-based Research?

BioFortis

Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems.  Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
More info >>

 
Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement